INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![GettyImages-2024666721-meeting-table-office-business-man-doctors]( "Site Engagement Doesn't Start At First Patient In")
Site Engagement Doesn't Start At First Patient InSite engagement starts long before enrollment. Explore how well-designed investigator meetings can set the tone, build trust, and give site teams the momentum they need to deliver.
-
![early-oncology-trials-GettyImages-1796958784]( "Best Practices For Operationalizing Global, Early-Phase Oncology Trials")
Best Practices For Operationalizing Global, Early-Phase Oncology TrialsIn this presentation, industry experts will share real-world lessons learned from managing global early-phase oncology trials.
-
![Nurse, patient, and daughter talking about prescription medication in a hospital-GettyImages-2210890101]( "The Triple Effect Of Community-Based Clinical Trials")
The Triple Effect Of Community-Based Clinical TrialsTaking trials into local communities improves access, boosts enrollment, reduces dropouts, and yields more representative data, speeding timelines and strengthening study quality.
-
![GettyImages-1181024482 payment]( "Stipends Create More Tax Burden — Here's A Better Option")
Stipends Create More Tax Burden — Here's A Better OptionExplore the tax reporting requirements, including the threshold for payments requiring a 1099 form rising from $600 to $2,000 in 2026.
-
Before You Invest: A Clinical Trial Payment Technology Checklist7/13/2026
Outdated payment workflows create delays, financial blind spots, and administrative strain in clinical trials. Evaluating integrated, real-time solutions helps reduce burden, improve visibility, and support more efficient, scalable trial execution.
-
3 Reasons Sponsors Should Own The RTSM Vendor Relationship2/25/2026
Explore how direct management of study randomization and supply chains reduces communication delays, improves system design, and protects clinical data integrity from accidental unblinding.
-
How We Used Intelligent Automation to Transform Vendor Selection7/2/2025
Discover how your small biotech can achieve faster timelines, improved cost control, and more strategic, transparent choices with a platform leveraging intelligent automation.
-
The Realities Reshaping Phase I Trials For Sponsors9/15/2026
Phase I trials increasingly enroll patients and use expansion cohorts. Learn what this shift means for IRB review and sponsor planning.
-
Strong Bookings And The Disruption Gap Nobody Is Talking About5/6/2026
Understand the real impact of AI on CRO valuations and clinical trial stability. Explore why market data contradicts the "disruption" narrative and what it means for the future of the industry.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-2163190867-hospital-doctor-administrator-discussion]( "Sponsors And CROs")
Our aim is to ensure the flawless and successful execution of clinical research, maximizing its impact on both patients and the commercial market.
-
![Patient Satisfaction survey-GettyImages-1356228571]( "Elevating Success: The Crucial Role Of Customer Satisfaction Programs In Companies")
By examining how satisfaction data is gathered, interpreted, and acted upon, we highlight a framework intended to strengthen relationships and enhance service quality.
-
![GettyImages-1420647055 payments]( "Our Technology")
Built From The Ground Up
Block Clinical understood from the beginning that intuitive technology that integrates openly with other systems and suppliers is the key to a streamlined, affordable solution.
-
![clinical-drug-development-GettyImages-1354172647]( "Drug Safety And Pharmacovigilance Services")
Navigating drug safety in the era of innovation-driven medicine
The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
-
![Science technology, Research and Development, Drug discovery-GettyImages-1209661917]( "Purposed-Built For ADC Development")
Bispecific ADCs are reshaping cancer care. Early-phase development is critical, requiring agile CRO support, scientific depth, and real-time data to guide biotech sponsors toward long-term success.
